Clinical Trial Update: A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)

View source ↗

Summary

A completed prospective study evaluating acute cardiovascular effects of first-line sunitinib in metastatic renal cell carcinoma, with focus on cardiotoxicity, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Renal Cell Carcinoma, Cardiotoxicity | Status: COMPLETED